-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Hepion Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
- Hepion Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.2M, a 88.5% increase year-over-year.
- Hepion Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$19.3M, a 60.1% increase year-over-year.
- Hepion Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was -$19.3M, a 60.1% increase from 2023.
- Hepion Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$48.4M, a 6.51% decline from 2022.
- Hepion Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$45.5M, a 49.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)